Welcome to our Evotec Blog.

Hope you will find our articles and resources relevant for your projects and interests.

Our experts are available for any additional information and to assist with your project challenges!

Just contact us.

 

 

2016

Aptuit and Icagen agree to strategic alliance
Jim Regan, 22 February 2016

Alliance to Provide Drug Discovery Customers Access to Industry Leading Ion Channel and Transporter Technologies Greenwich, CT, February 22nd, 2016 - Aptuit LLC and Icagen, Inc. today announced a strategic alliance to give drug discovery customers access to ion channel and transporter technologies and expert services.Aptuit LLC, a premier global...

2015

Appointment of Aptuit as a member of EU-NETVAL
Jim Regan, 14 December 2015

We are very pleased to announce that Aptuit has been included into the select network of EU-NETVAL (European Union Network of Laboratories for the Validation of Alternative Methods) laboratories. Acceptance to EU-NETVAL is restricted to laboratories experienced in advanced in vitro procedures, and can demonstrate test systems and measurement...

Aptuit announces 16M$ investment in capacity and capability
Jim Regan, 7 December 2015

Significant increase in headcount, new capabilities in discovery and incremental increase in capacity in CMC Greenwich, CT, December 7th, 2015 -  Aptuit LLC announced it has commenced a growth program for 2016 to meet significant increase in demand from our customers in discovery, Chemistry, Manufacturing and Controls (CMC) and non-clinical...

Aptuit CEO, Jonathan Goldman, joins the Columbia University Healthcare Advisory Board
Jim Regan, 30 November 2015

Greenwich, CT, November 30, 2015 - We are very pleased to announce that Jonathan Goldman, CEO of Aptuit, has accepted a nomination to join the Columbia University Healthcare Advisory Board. Jonathan will serve an initial three-year term on the board alongside other executives from leading pharmaceutical and healthcare principals, thought...

 

 

Contact us

Evotec

Business Development

T +44.(0)1235.86 15 61 T +1.732 329 2355 x3308